Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Aug 2;24(15):12357.
doi: 10.3390/ijms241512357.

Step-by-Step Double-Trouble OBAIRH and DMD Diagnosis in a One-Year-Old Boy

Affiliations
Case Reports

Step-by-Step Double-Trouble OBAIRH and DMD Diagnosis in a One-Year-Old Boy

Olga Shchagina et al. Int J Mol Sci. .

Abstract

We present a case of a combination of two rare hereditary disorders: obesity, adrenal insufficiency and red hair syndrome (OBAIRH) and Duchenne muscular dystrophy (DMD) in a boy. Both diseases were diagnosed during the first year of life. OBAIRH was suggested based on the ethnicity and family history of the patient, while DMD was based on an extreme increase in transaminase and CK (creatine kinase) levels during a biochemical analysis of his blood. The OBAIRH syndrome was caused by a pathogenic homozygous variant in the regulatory region of the POMC gene (NM_001035256.3): c.-71+1G>A, while DMD was caused by the de novo deletion of exons 38-45 of the DMD (NM_004006.3) gene (NC_000023.10:g.(?_32380941)(31950285_?)del).

Keywords: DMD; OBAIRH; POMC; double trouble.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The proband’s family tree. The arrow points to patient D. Plus signs indicate the examined and genotyped family members; dots—carriers of the c. –71+1G>A variant in the POMC gene; black colour—patients with OBAIRH. =: a sequence was found unchanged, 0: absence of the second X chromosome (hemizygote).

Similar articles

References

    1. Khudiakova E.S. Components of Ethnic Identity of Tatars of Perm Territory (According to Spontaneous Texts) Compon. Ethn. Identity Tatars Perm Territ. 2020;6:190–205. doi: 10.24224/2227-1295-2020-6-190-205. - DOI
    1. Rosstat—All-Russian Population Census. [(accessed on 23 June 2023)];2020 Available online: https://rosstat.gov.ru/vpn_popul.
    1. Weber F.J., Latshang T.D., Blum M.R., Kohler M., Wertli M.M. Prognostic Factors, Disease Course, and Treatment Efficacy in Duchenne Muscular Dystrophy: A Systematic Review and Meta-Analysis. Muscle Nerve. 2022;66:462–470. doi: 10.1002/mus.27682. - DOI - PMC - PubMed
    1. Deng J., Zhang J., Shi K., Liu Z. Drug Development Progress in Duchenne Muscular Dystrophy. Front. Pharmacol. 2022;13:950651. doi: 10.3389/fphar.2022.950651. - DOI - PMC - PubMed
    1. Graves L.E., Khouri J.M., Kristidis P., Verge C.F. Proopiomelanocortin Deficiency Diagnosed in Infancy in Two Boys and a Review of the Known Cases. J. Paediatr. Child Health. 2021;57:484–490. doi: 10.1111/jpc.15407. - DOI - PubMed

Publication types